Clinical Case Reports (Mar 2022)

Rare variant in the fumarate hydratase gene found in patients with clinical features of hereditary leiomyomatosis and renal cell cancer (HLRCC): A case series

  • Keith Franke,
  • Jennie Vagher,
  • Julie Boyle,
  • April Hall,
  • Kelcy Smith‐Simmer

DOI
https://doi.org/10.1002/ccr3.5513
Journal volume & issue
Vol. 10, no. 3
pp. n/a – n/a

Abstract

Read online

Abstract Hereditary leiomyomatosis and renal cell cancer (HLRCC) is an inherited cancer predisposition syndrome caused by autosomal dominant heterozygous pathogenic variants in the fumarate hydratase (FH) gene. FH pathogenic variant carriers are at an increased risk for cutaneous leiomyomas, renal cell cancer, and uterine fibroids. We present a case series of patients identified at two different medical institutions with clinically diagnostic features of HLRCC and a shared rare variant in the FH gene.

Keywords